000 | 01907 a2200613 4500 | ||
---|---|---|---|
005 | 20250517235048.0 | ||
264 | 0 | _c20190513 | |
008 | 201905s 0 0 eng d | ||
022 | _a1573-7365 | ||
024 | 7 |
_a10.1007/s11011-018-0295-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGuan, Zhu-Fei | |
245 | 0 | 0 |
_aEGb761 improves the cognitive function of elderly db/db _h[electronic resource] |
260 |
_bMetabolic brain disease _c12 2018 |
||
300 |
_a1887-1897 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAging _xdrug effects |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBeclin-1 _xagonists |
650 | 0 | 4 |
_aCognitive Dysfunction _xdrug therapy |
650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xdrug therapy |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aGinkgo biloba |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMaze Learning _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
650 | 0 | 4 |
_aPlant Extracts _xpharmacology |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
700 | 1 | _aZhang, Xiao-Ming | |
700 | 1 | _aTao, Ying-Hong | |
700 | 1 | _aZhang, Yu | |
700 | 1 | _aHuang, Yan-Yan | |
700 | 1 | _aChen, Gang | |
700 | 1 | _aTang, Wei-Jun | |
700 | 1 | _aJi, Gang | |
700 | 1 | _aGuo, Qi-Lin | |
700 | 1 | _aLiu, Ming | |
700 | 1 | _aZhang, Qian | |
700 | 1 | _aWang, Na-Na | |
700 | 1 | _aYu, Zhong-Yu | |
700 | 1 | _aWu, Guo-Feng | |
700 | 1 | _aTang, Zhou-Ping | |
700 | 1 | _aDu, Zun-Guo | |
700 | 1 | _aShang, Xi-Liang | |
700 | 1 | _aLiu, Ying-Chao | |
700 | 1 | _aMei, Guang-Hai | |
700 | 1 | _aGuo, Jing-Chun | |
700 | 1 | _aZhou, Hou-Guang | |
773 | 0 |
_tMetabolic brain disease _gvol. 33 _gno. 6 _gp. 1887-1897 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11011-018-0295-2 _zAvailable from publisher's website |
999 |
_c28807966 _d28807966 |